Basic Information
10 mEq Potassium Chloride in 5% Dextrose and 0.33% Sodium Chloride Injection, USP
INJECTION
Regulatory Information
SIN13224P
November 28, 2006
General Sale List
Therapeutic
INTRAVENOUS
January 24, 2024
May 30, 2025
XB05BB01
Company Information
BAXTER HEALTHCARE (ASIA) PTE LTD
BAXTER HEALTHCARE (ASIA) PTE LTD
Active Ingredients
Detailed Information
Contraindications
**4 CONTRAINDICATIONS** Potassium Chloride in Dextrose and Sodium Chloride Injection is contraindicated in patients with: - known hypersensitivity to potassium chloride, dextrose and/or sodium chloride _\[see Warnings and Precautions 5.1) – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information\]_ - clinically significant hyperkalemia _\[see Warnings and Precautions (5.2) – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information\]_ - clinically significant hyperglycemia _\[see Warnings and Precautions (5.3) – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information\]_
Indication Information
**1 INDICATIONS AND USAGE** Potassium Chloride in Dextrose and Sodium Chloride Injection is indicated as a source of water, electrolytes and calories.